Loading ...
Dionysis obtained his B.Sc. with honors at the Department of Pharmacy of the National and Kapodistrian University of Athens in 2021. He then proceeded to pursue a Master’s degree in Drug Design and Development at the same university, discussing an experimental thesis entitled “Design and Synthesis of Novel 2-Aryl-Quinazoline-4-one derivatives as potential Tankyrase Inhibitors with Anticancer Activity”. After having successfully completed his Master’s in 2023, he is currently enrolled in a co-tutelle PhD program at the University of Bologna in agreement with the University of Lisbon, within the TClock4AD Doctoral Network. His work is focused on the design and synthesis of Multi-Target Directed Ligands (MTDLs) that modulate and alleviate circadian clock dysfunction in Alzheimer's Disease.
PhD Title: “Circadian Polypharmacology in AD: Discovery of Multitarget-Directed Ligands”
Supervisor #1: Dr. Elisa Uliassi, Alma Mater Studiorum University of Bologna
Supervisor #2: Prof. Rita Guedes, University of Lisbon
